Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany—The Impact of Healthcare Structures

International Journal of Environmental Research and Public Health

Ron Hendrix¹  Corinna Glasner¹  AlexanderW. Friedrich¹  Karsten Becker²  Robin Köck³  EvgenyA. Idelevich⁴  Annette Jurke⁵ 

[1] Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700RB Groningen, The Netherlands;Friedrich-Loeffler-Institute for Medical Microbiology, University of Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany;Institute of Hygiene, DRK Kliniken Berlin, Spandauer Damm 130, 14050 Berlin, Germany;Institute of Medical Microbiology, University Hospital Münster, Domagkstraße 10, 48149 Münster, Germany;Landeszentrum Gesundheit NRW, Gesundheitscampus 10, 44801 Bochum, Germany;

关键词: antimicrobial resistance;    Euregio;    MRSA;    ESBL;    MDRO;    infection prevention;   

DOI  :  10.3390/ijerph17072337

来源: DOAJ

【 摘 要 】

The Netherlands and Germany are neighbouring countries within the European Union but are differently affected by multidrug-resistant microorganisms (MDRO). In this narrative review, we summarize data about antibiotic use, the occurrence of MDRO and healthcare-associated infections in these two countries, as well as data about organizational and structural differences between the Dutch and German healthcare systems. These results are discussed with a focus on whether or how the organization of healthcare influences MDRO prevention. We found that from the point of view of MDRO prevention, a higher density of inpatient care, a higher number of hospitals, a longer length of stay and lower staffing ratios might facilitate MDRO dissemination in German hospitals.

【 授权许可】

Unknown